Drug Type Small molecule drug |
Synonyms 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil, 2'-F-ara-deoxyuridine, 2'-Fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil + [2] |
Target |
Mechanism TYMS inhibitors(Thymidylate synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H11FN2O5 |
InChIKeyUIYWFOZZIZEEKJ-PXBUCIJWSA-N |
CAS Registry69123-94-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | US | 01 Jul 2009 | |
Adult Lymphoblastic Lymphoma | Phase 1 | US | 01 Jul 2009 | |
Adult T-Cell Leukemia-Lymphoma | Phase 1 | US | 01 Jul 2009 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Jul 2009 | |
Anaplastic Large-Cell Lymphoma | Phase 1 | US | 01 Jul 2009 | |
Burkitt Lymphoma | Phase 1 | US | 01 Jul 2009 | |
Chronic Lymphocytic Leukemia | Phase 1 | US | 01 Jul 2009 | |
Diffuse Large B-Cell Lymphoma | Phase 1 | US | 01 Jul 2009 | |
Extranodal NK-T-Cell Lymphoma | Phase 1 | US | 01 Jul 2009 | |
Follicular Lymphoma | Phase 1 | US | 01 Jul 2009 |